EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer

Satoshi Takamori iD, Marina Nakatsuka, Hikaru Watanabe, Jun Suzuki iD, Makoto Endo, Satoshi Shiono iD

European Journal of Cardio-Thoracic Surgery · 2025

DOI: 10.1093/ejcts/ezaf233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Satoshi Takamori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pneumonectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Tumour location can affect clinicians’ decisions regarding the surgical procedure, especially when choosing between lobectomy and segmentectomy. The biological behaviour of clinical stage I non-small cell lung cancer (NSCLC) may differ based on tumour location. We aimed to explore the biological behaviour of centrally located (CL) clinical stage I NSCLC and to identify which surgical procedure is more appropriate for such tumours.

Methods

This retrospective study included 719 patients who underwent curative operations for stage I NSCLC between April 2004 and December 2023. The biological behaviour of the tumours was analysed based on tumour location. Overall and recurrence-free survivals in patients who underwent lobectomy or more extensive procedures, including hilar and mediastinal lymph node dissection, were assessed based on tumour location.

Results

A total of 124 (17.2%) and 595 (82.8%) patients were included in the CL and peripherally located groups, respectively. The CL group had a significantly higher standardized uptake value maximum on positron emission tomography/computed tomography, a higher-grade adenocarcinoma subtype, and a higher frequency of lymph node metastasis than the peripherally located group. In multivariable analysis, CL and radiologically pure solid tumours (consolidation/tumour ratio = 1) were significant factors for occult lymph node metastasis. No significant difference was observed in survival based on tumour location.

Conclusions

Centrally located clinical stage I NSCLCs tend to be hypermetabolic and have a potential risk of lymph node metastasis. Lobectomy could be a better treatment option for CL clinical stage I NSCLC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsPneumonectomyHumansRetrospective StudiesMaleFemaleMiddle AgedNeoplasm StagingAgedPositron Emission Tomography Computed TomographyLymphatic MetastasisLymph Node Excision

Stichwörter der Autor:innen

lobectomylymph node metastasisnon-small cell lung cancersegmentectomytumor localization

Autor:innen und Institutionen

  • Department of Surgery II, Faculty of Medicine, Yamagata University, Yamagata 990-9585, Japan.
  • Department of Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata 990-2292, Japan.

ORCID-Profile: Satoshi Takamori, Jun Suzuki, Satoshi Shiono

Zitieren

APA

Takamori, S., Nakatsuka, M., Watanabe, H., Suzuki, J., Endo, M., & Shiono, S. (2025). Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf233

Vancouver

Takamori S, Nakatsuka M, Watanabe H, Suzuki J, Endo M, Shiono S. Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf233

BibTeX
@article{Takamori2025,
  author = {Takamori, Satoshi and Nakatsuka, Marina and Watanabe, Hikaru and Suzuki, Jun and Endo, Makoto and Shiono, Satoshi},
  title = {Lobectomy is the preferred choice rather than sublobar resection for centrally located clinical stage 1 non-small cell lung cancer},
  journal = {European Journal of Cardio-Thoracic Surgery},
  year = {2025},
  doi = {10.1093/ejcts/ezaf233}
}
Kostenlos starten →